WITHDRAWN: Adipocyte Deletion of ADAM17 Leads to Insulin Resistance in Association with Age and HFD in Mice.


Journal

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484

Informations de publication

Date de publication:
05 2021
Historique:
entrez: 28 7 2021
pubmed: 29 7 2021
medline: 29 7 2021
Statut: ppublish

Résumé

Withdrawal: Valeria Lopez Salazar, Rhoda Anane Karikari, Lun Li, Rabih El-Merahbi, Maria Troullinaki, Moya Wu, Tobias Wiedemann, Alina Walth, Manuel Gil Lozano, Maria Rohm, Stephan Herzig, Anastasia Georgiadi. Adipocyte Deletion of ADAM17 Leads to Insulin Resistance in Association with Age and HFD in Mice (2021). The FASEB Journal. 35:s1. doi: 10.1096/fasebj.2021.35.S1.00447. The above abstract, published online on May 14, 2021 in Wiley Online Library (wileyonlinelibrary.com), has been withdrawn by agreement between the authors, FASEB, and Wiley Periodicals Inc. The withdrawal is due to a request made by the authors prior to publication. The Publisher apologizes that this abstract was published in error.

Identifiants

pubmed: 34318951
doi: 10.1096/fasebj.2021.35.S1.00447
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : DAAD Forschungsstipendien - Promotionen in Deutschland
ID : 2017/18

Informations de copyright

© FASEB.

Auteurs

Valeria Lopez Salazar (V)

Institute for Diabetes and Cancer IDC, Institute for Diabetes and Cancer, Helmholtz Zentrum München, German Research Center, Neuherberg.

Rhoda Anane Karikari (RA)

Institute for Diabetes and Cancer IDC, Institute for Diabetes and Cancer, Helmholtz Zentrum München, German Research Center, Neuherberg.

Lun Li (L)

Institute for Diabetes and Cancer IDC, Institute for Diabetes and Cancer, Helmholtz Zentrum München, German Research Center, Neuherberg.

Rabih El-Merahbi (R)

Institute for Diabetes and Cancer IDC, Institute for Diabetes and Cancer, Helmholtz Zentrum München, German Research Center, Neuherberg.

Maria Troullinaki (M)

Institute for Diabetes and Cancer IDC, Institute for Diabetes and Cancer, Helmholtz Zentrum München, German Research Center, Neuherberg.

Moya Wu (M)

Institute for Diabetes and Cancer IDC, Institute for Diabetes and Cancer, Helmholtz Zentrum München, German Research Center, Neuherberg.

Tobias Wiedemann (T)

Institute for Diabetes and Cancer IDC, Institute for Diabetes and Cancer, Helmholtz Zentrum München, German Research Center, Neuherberg.

Alina Walth (A)

Institute for Diabetes and Cancer IDC, Institute for Diabetes and Cancer, Helmholtz Zentrum München, German Research Center, Neuherberg.

Manuel Gil Lozano (M)

Institute for Diabetes and Cancer IDC, Institute for Diabetes and Cancer, Helmholtz Zentrum München, German Research Center, Neuherberg.

Maria Rohm (M)

Institute for Diabetes and Cancer IDC, Institute for Diabetes and Cancer, Helmholtz Zentrum München, German Research Center, Neuherberg.

Stephan Herzig (S)

Institute for Diabetes and Cancer IDC, Institute for Diabetes and Cancer, Helmholtz Zentrum München, German Research Center, Neuherberg.

Anastasia Georgiadi (A)

Institute for Diabetes and Cancer IDC, Institute for Diabetes and Cancer, Helmholtz Zentrum München, German Research Center, Neuherberg.

Classifications MeSH